Dziubla:Research: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
The past 15 years of biomaterials research have resulted in multiple active polymer concepts (e.g. polymer prodrugs, drug targeting, nanoparticles, responsive materials) which all have exciting implications in advancing medical care. Our group’s interest is in adapting these exciting concepts into coherent materials and devices which can be applied to specific medical applications. This narrow in scope design approach provides a means for translational biomaterials research while simultaneously permitting the discovery of unmet biomaterial needs.<p> | The past 15 years of biomaterials research have resulted in multiple active polymer concepts (e.g. polymer prodrugs, drug targeting, nanoparticles, responsive materials) which all have exciting implications in advancing medical care. Our group’s interest is in adapting these exciting concepts into coherent materials and devices which can be applied to specific medical applications. This narrow in scope design approach provides a means for translational biomaterials research while simultaneously permitting the discovery of unmet biomaterial needs.<p> | ||
This approach has manifested into two main research trusts within our laboratory, antioxidant polymer nanocarriers and post-surgical adhesion barriers. | This approach has manifested into two main research trusts within our laboratory, antioxidant polymer nanocarriers and post-surgical adhesion barriers. | ||
Recently, we have been researching ways to inhibit the ability of emerging resistant bacterias and infections through the use of our antioxidant polymers. | |||
|} | |} | ||
Revision as of 09:39, 25 May 2011
People Principal Investigator Undergraduates --- Past Graduate Students Past Undergraduates
Past High school Students |
ContactThomas Dziubla |
|
The past 15 years of biomaterials research have resulted in multiple active polymer concepts (e.g. polymer prodrugs, drug targeting, nanoparticles, responsive materials) which all have exciting implications in advancing medical care. Our group’s interest is in adapting these exciting concepts into coherent materials and devices which can be applied to specific medical applications. This narrow in scope design approach provides a means for translational biomaterials research while simultaneously permitting the discovery of unmet biomaterial needs. This approach has manifested into two main research trusts within our laboratory, antioxidant polymer nanocarriers and post-surgical adhesion barriers. Recently, we have been researching ways to inhibit the ability of emerging resistant bacterias and infections through the use of our antioxidant polymers. |
